AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Nov 6, 2013
30016_dirs_2013-11-06_6756a4f6-b81a-43cb-b2ba-624b7252893d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-11-04
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-04 | Common Stock | M | 3834 | $53.31 | Acquired | 13642 | Direct |
| 2013-11-04 | Common Stock | M | 3942 | $56.95 | Acquired | 17584 | Direct |
| 2013-11-04 | Common Stock | M | 2 | $34.37 | Acquired | 17586 | Direct |
| 2013-11-04 | Common Stock | S | 6020 | $108.1912 | Disposed | 11566 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-04 | Non-Qualified Stock Option (right to buy) | $53.31 | M | 3834 | Disposed | 2017-02-13 | Common Stock (3834) | Direct |
| 2013-11-04 | Non-Qualified Stock Options (right to buy) | $56.95 | M | 2186 | Disposed | 2015-02-13 | Common Stock (2186) | Direct |
| 2013-11-04 | Incentive Stock Option (right to buy) | $56.95 | M | 1756 | Disposed | 2015-02-13 | Common Stock (1756) | Direct |
| 2013-11-04 | Incentive Stock Option (right to buy) | $34.37 | M | 2 | Disposed | 2016-02-13 | Common Stock (2) | Direct |
Footnotes
F1: Includes 54 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2013.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $108.0200 to $108.4400, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013 and 02/14/2014 and the remaining 1,959 shares on 02/14/2015.
F4: Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011 and the remaining 2,186 shares on 02/14/2013.
F5: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011 and the remaining 1,755 shares on 02/14/2013.
F6: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013 and the remaining 2,909 shares on 02/14/2014.